Idera Pharmaceuticals (United States)

About

In recent decades, authors affiliated with Idera Pharmaceuticals (United States) have published 331 papers, which have received a total of 15.0k indexed citations. Scholars at this organization have produced 112 papers in Molecular Biology, 104 papers in Immunology and 57 papers in Infectious Diseases on the topics of HIV/AIDS drug development and treatment (50 papers), Hepatitis C virus research (46 papers) and Monoclonal and Polyclonal Antibodies Research (37 papers). Their work is cited by papers focused on Molecular Biology (5.8k citations), Immunology (3.4k citations) and Epidemiology (3.2k citations). Authors at Idera Pharmaceuticals (United States) collaborate with scholars in United States, Switzerland and France and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Idera Pharmaceuticals (United States)'s most productive authors include Joan S. Brugge, Sudhir Agrawal, Ekambar R. Kandimalla, RA Newman, JE Leonard, Kevin J. Tomaselli, Lawrence C. Fritz, Laurie Jackson‐Grusby, Caroline Beard and Ulf Pettersson.

In The Last Decade

Idera Pharmaceuticals (United States)

320 papers receiving 15.0k citations

Fields of papers published by authors at Idera Pharmaceuticals (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Idera Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Idera Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Idera Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Idera Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Idera Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idera Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026